7 results about "Symptom relief" patented technology

The invention belongs to the technical field of microorganisms, and particularly relates to bifidobacterium animalis for relieving eye allergy and application of the bifidobacterium animalis. The invention provides an application of bifidobacterium animalis subsp. Lactis in preparation of a product for relieving eye allergy, the bifidobacterium animalis subsp. Lactis is Def +, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.35798. The Bifidobacterium animalis subsp. Lactis Def < + > provided by the invention can relieve the eye itching symptom, relieve red and swollen eyelids, reduce conjunctiva and cornea injury, relieve eye discomfort, relieve globular conjunctivitis cell infiltration, improve corneal epithelium thickening lesion, improve the anti-inflammatory ability and improve allergic conjunctivitis, keratitis and blepharitis marginata in a targeted manner. The eye drops are high in safety and resistant to gastrointestinal fluid, and a safe and long-acting scheme is provided for eye allergic diseases.

Provided is a composition for visual field defect disorders, glaucoma, light-induced ocular tissue damage and related disorders, which can be used as a food or drug for long-term administration, prevention, symptom relief and improvement. A composition comprising a triglyceride represented by the formula (I):(wherein R1, R2, and R3 are each a saturated fatty acid residue, and at least one of them is a pentadecanoic acid residue) as an active ingredient.

The invention belongs to the field of marker detection, and particularly relates to a marker for diagnosing or identifying potential causes of migraine, application, a kit, a device and an evaluation model. The invention provides a marker for diagnosing or identifying potential causes of migraine. The marker comprises indoleacrylic acid and / or hypersensitive C-reactive protein. The invention reveals that PFO is combined with migraine metabonomics maps, and branched chain amino acid metabolism, neurosteroid metabolism and tryptophan metabolism disorder are core pathological mechanisms for the first time. On the basis of plasma metabonomics characteristics of a PFO-combined migraine patient and a healthy control, 211 metabolites with significant difference are screened out, it is found that various metabolites are significantly related to the symptom severity of migraine, and two factors [indoleacrylic acid and hypersensitive C-reactive protein (hs-CRP)] significantly related to migraine related to patent foramen ovale are confirmed. In addition, the concentration of indolecrylic acid (IA) is found to have a relatively good prediction value on symptom relief after occlusion.

This invention belongs to the field of anti-snoring technology, specifically a silicone anti-snoring device. It comprises an integrally molded silicone body consisting of an occlusal pad, an upper labial shield, a tongue induction screen, and a lower labial shield. Both ends of the upper and lower labial shields extend to the end face of the occlusal pad via buccal screens. A connecting portion exists between the occlusal pad and the tongue induction screen. This connecting portion is smooth and without protrusions in the Z-axis, and the corner surface of the occlusal pad away from the connecting portion is smooth. The smooth and non-protruding connecting portion in the Z-axis eliminates the palatal base of the maxillary teeth, making the tongue more easily lifted by the tongue induction screen. The tongue induction screen pushes the tongue from the floor of the mouth to the palatal side of the upper teeth, opening the airway and achieving buccal and lingual muscle balance. Patients can choose one, two, or three stages of mandibular protraction treatment based on their snoring symptom relief and temporomandibular joint symptoms. By protruding the mandible, the airway is further opened.

This invention relates to the technical field of targeted drug screening, specifically to a targeted drug screening system for host-interacting proteins of the atrial fluid inflamed eye syndrome (AIBS). The technical solution acquires multidimensional heterogeneous data of AIBS patients through a data acquisition terminal, and vectorizes this data through a processing terminal to obtain a first vector of clinical manifestation characteristics and a second vector of interaction protein manifestation characteristics for each patient. Based on the first and second vectors, a set of coefficients of variation (CVs) representing the relative differences in various manifestation characteristics is obtained. Based on the current patient's characteristic standard values ​​for drugs and clinical outcomes, the CV set, and the affinity and effects of different targeted drugs, the matching degree and symptom relief potential of different targeted drugs for the current patient are obtained. Based on the matching degree and symptom relief potential of each targeted drug, the drug screening results for the current patient are output. This technical solution enables each patient to accurately screen suitable drugs for the treatment of AIBS based on multidimensional heterogeneous data.

The invention belongs to the technical field of biological medicine, and discloses disposable eye lotion for double-effect repair of cornea and a preparation method of the disposable eye lotion. The eye moistening liquid comprises 0.1-0.3% by mass volume of sodium hyaluronate with the weight-average molecular weight of 50,000-200,000 Da and 0.05-0.2% by mass volume of chitosan with the number-average molecular weight of 3,000-10,000 Da and the deacetylation degree of more than or equal to 85%, the mass ratio of the sodium hyaluronate to the chitosan is 2: 1-6: 1, a phosphate buffer system and sodium chloride are used for adjusting the pH value to 6.5-7.8, and the osmotic pressure is 260-340 mOsm / KgH2O. The functional limitation that traditional eye moistening liquid is only limited to symptom relieving is broken through, a prevention and repair integrated ocular surface nursing solution is constructed, the product has the double-effect functions of instant lubrication and promotion of corneal epithelial cell migration and proliferation and barrier reconstruction under the preservative-free condition, and the product is stable in physicochemical property, high in safety and suitable for popularization and application. A novel intervention means with safety, effectiveness and convenience is provided for contact lens related ocular surface damage.

Formulations comprising hydrocortisone are disclosed in a suppository for methods of treating ulcerative colitis and other gastrointestinal diseases and disorders. Administering a single hydrocortisone suppository once a day achieves remission or reduction of a symptom, optionally followed by a period of time in which the dosage is reduced.